Characteristics, Treatment Options for Patients With Advanced Gynecologic Cancers
The management of advanced gynecologic cancers remains a challenge, but the treatment landscape is changing.
The management of advanced gynecologic cancers remains a challenge, but the treatment landscape is changing.
Researchers found a similarly increased risk of breast cancer for progestogen-only contraceptives and oral combined contraceptives.
Molecular testing may be underused in patients with metastatic NSCLC and may delay the start of systemic therapy, a study suggests.
Drug shortages in the United States increased nearly 30% between 2021 and 2022, according to a Senate report.
The FDA has granted accelerated approval to Zynyz (retifanlimab) for the treatment of adults with metastatic or recurrent locally advanced Merkel cell carcinoma.
Residual variants are associated with a higher risk of relapse and death among AML patients undergoing HSCT in first remission, a study suggests.
Mammography use is still higher among White patients than among American Indian patients, but the gap is narrowing due to declining mammography use in White patients.
Antibiotics may prevent bacteria-mediated chemoresistance in patients with metastatic pancreatic cancer, a new study suggests.
Patients with solid tumors do not appear to have an increased risk of side effects from COVID-19 vaccination, according to a systematic review.
Adding ipilimumab to nivolumab and chemotherapy improves responses in patients with operable non-small cell lung cancer, a phase 2 trial suggests.